Implante de válvula aórtica transcatéter. Una revisión de las vías de abordaje

Albarova, Oscar Gil; Juez, Marina; Berenguer, Alberto; Sanmiguel, Darío; Gonzalez, Javier Sirgo

doi:10.1016/j.circv.2016.06.002

Cited by 2 publications

(5 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Potential complications of the TAo route are the same as those of the TF route. Perforation of the left ventricle and various injuries resulting from the use of extra stiff guidewire have been described, but they are now very rare given the use of preformed guidewires and careful manipulation of the guidewire within the ventricular cavity 17 .…”

Section: Discussionmentioning

confidence: 99%

“…The most commonly used access is transfemoral (TF), which is the first option in most centers; however, there is a group of patients in whom TF access is not possible due to the size, tortuosity, or calcification of the femoral vessel. As a consequence, non-TF access alternative routes have been developed, which include transapical, transaortic (TAo), axillary, subclavian, and transcarotid access 3,4 . There are studies where femoral access was associated with a lower 30-day and 1-year mortality rate in comparison with non-TF access 5,6 , while others compare TF access with TAo and transapical access, with higher 30-day and 1-year mortality being shown in the transapical group 7 .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Initial experience in Mexico with the EvolutÓ� R valve with direct aortic Access

Gutiérrez-Leonard

Martín-Hernández

Ojeda-Delgado

et al. 2023

ACME

View full text Add to dashboard Cite

Background: Aortic stenosis (AS) is one of the most frequent valvulopathies in elderly patients. The treatment for AS is heart surgery; however, many patients do not benefit from this treatment because they are considered to be at high surgical or inoperable risk. Transcatheter aortic valve implantation (TAVI) was developed for these patients. Objective: To disseminate the feasibility and safety of other access routes for the implantation of transcatheter aortic valves and that it can also be performed in the hemodynamic laboratory. In addition to the rapid growth in technology and knowledge, there is a lot of experience with TAVI already. Methodology: One of the limitations is the diameter of the femoral, subclavian, and axillary vascular accesses. This is why other approaches such as the direct aortic approach are sought after, despite the invasive nature of mini-thoracotomy and aortotomy is technically feasible, familiar, and easy to learn for cardiac surgeons. Results: In addition, it has been associated with favorable outcomes and a lower rate of complications (bleeding and risk of myocardial injury) and shorter length of stay in the intensive care unit compared to surgery or transapical access. Conclusions: Our center successfully implanted the self-expandable aortic valve Evolut™ through direct aortic for presenting a dissection in transverse aorta with possibilities of embolization.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Initial experience in Mexico with the EvolutÓ� R valve with direct aortic Access

Gutiérrez-Leonard

Martín-Hernández

Ojeda-Delgado

et al. 2023

ACME

View full text Add to dashboard Cite

show abstract

“…Las complicaciones potenciales de la vía TAo son las mismas que las de la vía TF. Se ha descrito la perforación del ventrículo izquierdo y diversas lesiones derivadas del empleo de la guía extrastiff, pero ya son muy raras dado el empleo de guías preformadas y la manipulación cuidadosa de la guía dentro de la cavidad ventricular 17 .…”

Section: Discussionunclassified

“…Hugo Gutiérrez-Leonard 1 , Patricia Martín-Hernández 1 *, José L. Ojeda-Delgado 1 , Miguel A. Corona-Perezgrovas 2 , Lázaro Hernández-Jiménez 1 , Jorge Fagoaga-Valdivia 2 , María del R. Blázquez-Cruz 3 , Victoria Rebollo-Hurtado 4 y Pedro Echeverría-Béliz 5 1 Laboratorio de Cateterismo Cardíaco, Departamento de Radiología Invasiva; 2 Departamento de Cirugía Cardiovascular; 3 Departamento de Ecocardiografía; 4 Departamento de Tomografía Computarizada. Hospital Central Militar, Ciudad de México, México; 5 Proctor Internacional de TAVI.…”

Section: Initial Experience In Mexico With the Evolut™ R Valve With Direct Aortic Accessunclassified

“…El acceso más comúnmente utilizado es el transfemoral (TF), siendo la primera opción en la mayoría de los centros; sin embargo, hay un grupo de pacientes para quienes el acceso TF no es posible debido al tamaño, la tortuosidad o la calcificación del vaso femoral. Como consecuencia, se han desarrollado rutas alternativas de acceso no TF, como son: el transapical, transaórtico (TAo), axilar, subclavio y transcarotídeo [3][4] . Existen estudios en donde el acceso femoral se asoció con menor tasa de mortalidad a 30 días y un año en comparación con el acceso no TF [5][6] , mientras otros comparan el acceso TF con el TAo y el transapical, mostrando mayor mortalidad a los 30 días y a un año en el grupo transapical 7 .…”

Section: Introductionunclassified

See 1 more Smart Citation